CytoAgents Newsroom

Media Coverage
November 10, 2021
TECH 50 2021: HONORING PITTSBURGH’S TOP TECH COMPANIES

The Pittsburgh Technology Council celebrated the 25th annual Tech 50 Awards on Nov. 10, 2021 to honor the fastest growing and most innovative technology companies, service providers and CEOS in the Pittsburgh region.
Media Coverage
May 11, 2023
CytoAgents Announces FDA Acceptance of IND Application for CTO1681 to Treat Cytokine Release Syndrome in Oncology

PITTSBURGH–(BUSINESS WIRE)–CytoAgents, Inc., a clinical-stage biotechnology company developing a safe, effective treatment for Cytokine Release Syndrome (CRS), today announced that it has received a Study May Proceed letter from the U.S. Food and Drug Administration…

Press Release
May 02, 2023
EY Announces Teresa Whalen, RPh, CEO of CytoAgents as an Entrepreneur Of The Year® 2023 East Central Award Finalist

Ernst & Young LLP (EY US) today announced that Teresa Whalen, RPh, CEO of CytoAgents, was named an Entrepreneur Of The Year® 2023 East Central Award finalist.

Media Coverage
January 01, 2023
Our Region’s Business – CytoAgents

As Teresa Whalen says in her “Our Region’s Business” interview hosted by Bill Flanagan on WPXI-TV, “2023 will be a breakout year for CytoAgents.”

Press Releases
View all of the latest news and announcements from CytoAgents
Read Press Releases
Media coverage
Read what the media has to say about CytoAgents
Read Media Coverage
Events
Learn about past and upcoming events for CytoAgents
View Events

Interested in Learning More about CytoAgents?

Contact us